InterShunt Technologies, Inc.
Lisa Ingham serves as the VP of Clinical & Regulatory Affairs at InterShunt Technologies, Inc. since May 2025, while also operating as a Global Clinical Research Consultant for Ingham Clinical Consulting, LLC since 2018. Previously, Lisa held the position of VP of Clinical Affairs at Surgical Information Sciences Inc. from September 2022 to May 2025 and served as the Director of Clinical Affairs at both RTI Surgical® and Atritech from 2014 to 2018 and 2009 to 2013, respectively. Lisa's earlier roles include Senior Principal Consultant at Alquest from 1999 to 2009 and Clinical Study Manager at MDS Harris from 1996 to 1998. Lisa completed a Bachelor's Degree at the University of Minnesota.
This person is not in any teams
This person is not in any offices
InterShunt Technologies, Inc.
InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe theycan do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.